[The macula in Adamantiades-Behçet disease]

Area of Science:

• Ophthalmology
• Rheumatology
• Systemic Inflammatory Diseases

Context:

• Adamantiades-Behçet disease (A-B disease) is a recognized inflammatory condition prevalent in Mediterranean regions.
• Ocular manifestations, particularly macular involvement, are frequently underestimated due to concurrent anterior segment or vitreous inflammation.
• Optic disc atrophy is a common cause of blindness, but macular sequelae significantly impair visual acuity.

Purpose:

• To retrospectively analyze macular alterations in Adamantiades-Behçet disease patients.
• To detail the specific findings related to macular complications in a cohort of 100 A-B disease cases.
• To evaluate the efficacy of various therapeutic interventions for macular involvement.

Summary:

• A retrospective study examined 100 consecutive Adamantiades-Behçet disease patients, focusing on detailed analysis of macular alterations.
• Macular sequelae, often masked by anterior segment inflammation, were identified as a primary cause of reduced visual acuity.
• Treatment strategies included corticosteroids, Cyclosporine A, and argon laser photocoagulation, with long-term follow-up results discussed.

Impact:

• Highlights the critical role of macular assessment in Adamantiades-Behçet disease management.
• Provides insights into the long-term visual outcomes and therapeutic effectiveness for ocular complications.
• Emphasizes the need for vigilant monitoring of macular health to prevent irreversible vision loss in A-B disease patients.